Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-021233·Applied Therapeutics, Inc.
Schedule 13G ownership disclosure
APPLIED THERAPEUTICS INC
Common Stock, $0.0001 par value per share · CUSIP: 03828A101
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLC
Shares: 2,860,000 · Class: 2.4%
- Joseph Edelman
Shares: 2,860,000 · Class: 2.4%
- Perceptive Life Sciences Master Fund, Ltd.
Shares: 2,860,000 · Class: 2.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-021233
- Form type
- SCHEDULE 13G/A
- Filer
- Applied Therapeutics, Inc.
- CIK
- CIK 1697532
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership